PRKDC and cancer: Genomic instability associated with cancer may provide targetable vulnerabilities for cancer therapy [8], and given the critical role of DNA-PK in DDR pathways, targeting this protein may be a promising strategy to increase the effectiveness of cancer therapy [6,18].